obesity treatment with bariatric surgery vs glp-1 receptor agonists Laparoscopic adjustable gastric banding liraglutide in adults with and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial Metabolic Bariatric Surgery vs. GLP-1

SeekPeptides covers all these medications in detail through comprehensive comparison guides and dosing resources

Oral formulations might enable obesity treatment to move decisively into primary care, extending its reach well beyond todays specialist base and giving access to greater numbers of patients earlier in the course of the disease

Obes Rev 22 Suppl 4: e13296, 2021

This new article analyses the evolution of the pipeline and market for obesity drugs, which is being transformed by GLP-1-based therapies nature.com/articles/d4157 This new article analyses the evolution of the pipeline and market for obesity drugs, which is being transformed by GLP-1-based therapies nature.com/articles/d4157

Together, they create a more comprehensive attack on obesity than either achieves alone

Regulatory approvals for weight management indications and growing awareness of the risks associated with obesity are driving these segments' explosive growth